ABSTRACT-To explore the mechanism of pulmonary fibrosis by bleomycin and its derivative, peplomycin (PLM), we examined the influence of PLM on signal transduction in human peripheral blood lymphocytes (HL), monocytes (HM) and fibroblasts (HF). Tyrosine phosphorylation of multiple proteins in HL and HM were induced by 0.001 to 0.05 mg/ ml and by 0.01 to 0.5 mg/ml of PLM, respectively. In HF, 116-kDa protein was phosphorylated 0.2 to 5 mg/ ml of PLM. When HL were treated with 0.01 mg/ ml of PLM, phosphorylation of p56 lck and activation of extracellular-signal related kinase-2 (ERK2) were induced. ERK2 was also activated in HM. Coordinately, the ratio of p21 ras -binding GTP/ GDP was increased by PLM. As well as interleukin-2, PLM induced tyrosine phosphorylation of JAK-3. In addition, PLM upregulated the nuclear translocation of nuclear factor-kappa B and the expression of c-myc-mRNA in HL, HM and HF. Furthermore, 0.01 to 0.001 mg / ml PLM enhanced the cytokine generation by HL and HM, and 1 to 5 mg / ml PLM increased cytokine generation and collagen synthesis by HF. These upregulatory effects of PLM were abrogated by pretreatment of the cells with a tyrosine kinase inhibitor. These results indicate that PLM upregulates signal transduction in a variety of cell types and the upregulation may induce pulmonary fibrosis.
Excellent therapeutic effects have been reported with peplomycin (PLM), a derivative of bleomycin, in squamous cell carcinoma, particularly in head and neck carcinomas. However, PLM may cause severe adverse effects, the major one being lethal pulmonary fibrosis (1, 2) . The use of this superior anticancer agent is limited because of this serious adverse effect.
Studies of the pathogenesis of PLM-induced pulmonary fibrosis have suggested increased blood vessel permeability (3), thrombosis resulting from increased blood platelet coagulants (4), the generation of reactive oxygen intermediates (ROI) from alveolar macrophages (5) , and apoptosis (6) as the mechanism of pulmonary fibrosis. Pulmonary tissue impairment by ROI appears to be one of the major pathophysiological features of PLM-induced pulmonary fibrosis because the tissue impairing effect of ROI has been demonstrated in pulmonary distress disease (7) . In the pulmonary impairment, cytokines may play critical roles by activating alveolar macrophages (8) and septal fibroblasts (9) to generate ROI and collagen, respectively.
We had demonstrated that PLM upregulated the generation of ROI, cytokines, and collagen in polymorphonuclear leukocytes, lymphocytes, and fibroblasts, respectively (9, 10) . Signals essential for the generation of ROI and proteins have to be transduced from the cell membrane to the nucleus. Activation of receptor type tyrosine kinase, G-protein and phosphatidylinositol-3-kinase (PI3-kinase) and phosphorylation of tyrosine residues of cytokine receptors-associated proteins and their downstream proteins are essential for the signal transduction (11 -13) . To upregulate the cytokine generation, transcription of the cytokine mRNA must to be increased by the transcription factors, for example, nuclear factor-kappa B (NF-k B), which is involved in multiple cytokine genes (14) . In T cells, Src family proteins transduce the signals by phosphorylating the tyrosine residues of proteins which are associated with them and the signals flow into the downstream mitogen-activated protein kinase, Rho, and Janus kinase (JAK)-signal transducers and activators of transcription (STAT) (15, 16) . If PLM is a stimulant of this signal transduction, then PLM-induced signals are finally transduced to the nucleus, resulting in activation of the transcription factors with induction of proto-oncogene expression. However, the influence of PLM on these molecular events has not yet been investigated. Exploration of the signal pathway in PLM-treated cells should lead to the resolution of the mechanism involved in PLM-induced pulmonary fibrosis. Along with this consideration, we examined the influence of PLM on protein tyrosine phos-phorylation, the activation of p21 ras and NF-kB, and the mRNA expression of c-myc proto-oncogene in human lymphocytes (HL), human monocytes (HM) and human fibroblasts (HF).
MATERIALS AND METHODS

Cell preparation
Peripheral blood mononuclear cells (PBMC) were isolated from heparinized peripheral blood obtained from healthy persons. After centrifugation on Ficoll-Paque (Amersham Pharmacia Biotech AB, Uppsala, Sweden) gradients, PBMC were collected from the surface layer of the gradients, washed three times in phosphate-buffered saline (PBS) and suspended in RPMI 1640 medium (Nissui Pharmaceutical Co., Ltd., Osaka) supplemented with Lglutamate, 10% (v/v) fetal bovine serum (FBS) and antibiotics. HL were then separated from HM, which were allowed to adhere to plastic dish surface for 1 h. Flow cytometry confirmed more than 95% purity of both HL and HM preparations.
HF were separated from the gingivae of healthy persons. The extirpated gingivae, from which the epithelial sheet was peeled off with a sharp knife, were minced into pieces of about 2 mm 3 , and these were cultured in Dulbecco's modified minimal essential medium (Nissui Pharmaceutical Co., Ltd.) containing L-glutamate, 10% (v/ v) FBS and antibiotics. After two to three passages, the proliferating fibroblasts were subjected to the experiments described below.
Western blot analysis
Suspensions (1´10 6 cells/ ml) of HF, HL, and HM were centrifuged, and the pelleted cells were resuspended and lysed in a buffer containing 125 mM Tris-HCl, pH 6.8, 2% (w/v) SDS, 10% (v/ v) glycerol, 5% (v / v) 2ME and 0.5 mM sodium orthovanadate. Immediately after the cell lysis, the lysates were boiled for 5 min and electrophoresed in a 7.5% or 10% SDS-polyacrylamide gel. Separated proteins were then electrophoretically transferred onto an Immobilon-P filter (Nippon Millipore Ltd., Tokyo). After incubation for 60 min in 3% (w/ v) skim milk (Difco Laboratories, Detroit, MI, USA) at room temperature, the filter was incubated with anti-phosphotyrosine monoclonal antibody (mAb) (Upstate Biotechnology, Inc., Lake Placid, NY, USA) or anti-phosphorylated extracellular-signal related kinase-1 (ERK1)/ ERK2 mAb (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA), and these antibodies were detected with peroxidase-conjugated rabbit anti-mouse IgG (Cappel Inc., West Chester, PA, USA). Peroxidase-positive bands were detected with an ECL Western blotting analysis system (Amersham Life Science, Ltd., Buckinghamshire, UK).
Immunoprecipitation
HL (1´10 7 cells) were treated as indicated in the figure legends, after which they were lysed in 500 ml of modified RIPA buffer [1% (v/ v) NP-40, 0.25% (w / v) sodium deoxycholate, 150 mM NaCl, 50 mM Tris-HCl, pH 7.5] containing 1 mM sodium orthovanadate, 1 mM PMSF, 10 mg/ml aprotinin and 10 mg/ ml leupeptin. After this 30 min lysis at 0°C, the cell lysates were centrifuged at 15,000´g for 10 min to remove the nuclear and cellular debris. The supernatants were immunoprecipitated for 2 h at 0°C with anti-JAK3 mAb (Upstate Biotechnology) or anti-p56 lck mAb (Santa Cruz Biotechnology). The immune complexes were recovered by incubation with 50 ml of protein ASepharose beads (Sigma Chemical Co., St. Louis, MO, USA) for 1 h at 0°C, and the beads were washed four times with lysis buffer, followed by one wash with TN buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl). The immunoprecipitated proteins were then eluted in SDS sample buffer, and analyzed by Western blotting analysis, as described above.
Analysis of GDP and GTP bound to p21 ras
P21
ras -bound guanine diphosphate (GDP) and guanine triphosphate (GTP) were analyzed by the method described by Downward et al. (17) . Briefly, HL (1´10 7 cells) were labeled with [
32 P]orthophosphate (18.5 MBq / ml; Amersham International plc, Amersham, UK) for 2 h in phosphate-free RPMI 1640 medium (Gibco, Tokyo). The labeled cells were treated with interleukin-2 (IL-2, 500 U/ ml) (Shionogi Pharmaceutical Co., Osaka) in the presence or absence of PLM (0.01 mg/ml) for 30 min, and they were washed with PBS and lysed in the buffer solution [20 mM Tris-HCl, pH 7.5, 5 mM MgCl2, 150 mM NaCl, 0.5% (v / v) NP-40, 1 m g/ml leupeptin and 0.2 mM PMSF]. The lysates were centrifuged at 12,500´g for 10 min, and the supernatant was incubated with anti-Ras mAb (Oncogene Science, Inc., Uniondale, NY, USA) for 1 h at 0°C. The immune complexes were added to rabbit anti-rat IgG antiserum (Cappel) bound to protein A-Sepharose beads and mixed gently for 1 h at 0°C. The immunoprecipitates were then washed three times with ice-cold washing buffer (50 mM Tris-HCl, pH 7.5, 20 mM MgCl2 and 150 mM NaCl) and suspended in 20 ml of solution containing 20 mM Tris-HCl, pH 7.5, 20 mM EDTA, 2% (w/ v) SDS, 0.5 mM GDP and 0.5 mM GTP. After heating at 65°C for 5 min, the suspension was centrifuged, and the supernatant was spotted onto a polyethyleneiminecellulose thin layer plate (MachereyNagel, Neumann-Neander, Germany) and developed with 0.75 M KH2PO4 (pH 3.4). The plate was exposed to Kodak XOMAT film (Eastman Kodak, Rochester, NY, USA) at -70°C for 24 to 72 h.
RNA extraction and reverse transcription
Total cellular RNA was extracted by using the RNeasy total RNA isolation system (Quiagen, Inc., Valentia, CA, USA), according to the manufacturer's protocols. The RNA was quantitated by measuring the optical density at 260 nm. The extracted RNA (1 m g) was added to 20 ml of reverse transcription buffer (50 mM Tris-HCl, pH 8.3, 50 mM KCl, 10 mM MgCl2, 1 mM EDTA, 10 mg/ml bovine serum albumin and 1 mM DTT) containing 10 mM dNTP, 50 U RNase inhibitor, 1 m g random hexadeoxynucleotide primer, and 50 U avian myeloblastosis virus reverse transcriptase (all from Boehringer Mannheim, Mannheim, Germany). This mixture was incubated at 42°C for 40 min and heated at 99°C for 5 min. The polymerase chain reaction (PCR) was performed with 4 m l of the cDNA preparation.
PCR
The prepared cDNA was added to the reaction mixture containing 10 mM Tris-HCl, pH 7.6, 50 mM KCl, 1.5 mM MgCl2, 0.01% (w/ v) gelatin, 0.2 mM dNTP, 0.4 m M of both 5' and 3' primers, and 2 U Taq polymerase (PerkinElmer Corp., Hayward, CA, USA) in a total volume of 50 ml. The reaction mixtures were overlaid with 50 ml mineral oil and incubated in a thermal cycler (PerkinElmer) for 45 s at 94°C, 45 s at 60°C, and 2 min at 72°C per cycle. The PCR products were electrophoresed in an agarose gel and visualized by staining with ethidium bromide. The quantities of the PCR products were determined by densitometric scanning using the NIH image software (US National Institutes of Health). Primers for c-myc and b-actin were purchased from Clontech Laboratories, Inc. (Palo Alto, CA, USA). For relative quantification, the densitometric value of each sample was normalized to b-actin.
Nuclear extracts and electrophosphoretic mobility shift assay (EMSA)
Nuclear extracts were prepared by the routine procedure. Briefly, 1´10
6 cells were centrifuged for 10 min at 100´g, washed in ice-cold PBS and centrifuged for 15 s at 12,500´g at 4°C. The cell pellets were washed once in 0.4 ml of buffer A (10 mM HEPES, pH 7.8, 10 mM PMSF, 5 mg/ ml antipain and 5 m g/ml leupeptin) and the cells suspended in buffer A were incubated on ice for 15 min. Then, 25 ml of 10% (v / v) NP-40 solution was added to the buffer, and the cells were vigorously agitated for 15 s and centrifuged for 30 s at 12,500´g. The pelleted nuclei were resuspended in 50 m l of buffer C [50 mM HEPES, pH 7.8, 50 mM KCl, 300 mM NaCl, 0.1 mM EDTA, 1 mM DTT, 0.1 mM PMSF, 10% (v / v) glycerol] and centrifuged for 5 min at 12,500´g after incubation for 20 min at 4°C. The supernatant containing the nuclear proteins was stored at -80°C until EMSA examination.
EMSA was performed according to a method described elsewhere. Binding reaction mixtures (20 m l) containing 5 mg sample protein (nuclear extract), 1 mg poly (dI) · poly (dC), 32 P-labeled probe (which binds to the consensus sequence), 50 mM NaCl, 0.2 mM EDTA, 0.5 mM DTT, 2% (v/v) glycerol, and 10 mM Tris-HCl, pH 7.5 were incubated for 20 min at 4°C, and proteins were separated by electrophoresis through a native 4% polyacrylamide gel in a running buffer consisting of 67 mM Tris-HCl, pH 7.5, 33 mM sodium acetate and 10 mM EDTA. The gel was dried and exposed to Kodak XOMAT film on intensifying screens for 5 to 15 h at -70°C after analysis by using an image analyzer (BAS2000; Fuji Photo Film Co., Ltd., Tokyo). The NF-k B probe (5'-GATCGAGGGGACTTTC CCTAGC-3', Gelshift™ assay kit; Stratagene, La Jolla, CA, USA) was labeled with [g-
32
P] ATP (Amersham International), using T4 polynucleotide kinase (Takara Biomedicals, Kyoto) and purified using a G-50 spin column.
Cytokine production and quantification HL, HM or HF (1´10 5 cells / ml) were cultured in the presence or absence of the indicated doses of PLM for 24 h. The culture supernatants were collected and subjected to cytokine titration. Cytokine levels were measured using enzyme-amplified sensitivity immunoassay kits (Medgenix Diagnostics, Brussels, Belgium) for IL-1b, granulocyte macrophage colony-stimulating factor (GM-CSF) and tumor necrosis factor-a (TNF-a), and with an enzyme-linked immunosorbent assay kit for IL-6 (Toray-Fuji Bionics, Inc., Tokyo).
Collagen synthesis assay
HF (5´10 4 cells /ml) were cultured in the presence or absence of the indicated doses of PLM for 48 h and pulsed with 185 kBq / ml of [ 3 H]proline (specific activity, 963 GBq/ mmol, Amersham International) and 50 mg/ml ascorbic acid (Nacalai Tesque, Kyoto) for 24 h. The cells were washed three times with PBS and dissolved in 0.5 ml of 0.1 M NaOH for 5 min at 37°C. Cellular proteins were precipitated with 0.5 ml of 10% (w /v) trichloroacetic acid (TCA) containing 0.4% (w/v) tannic acid (Nacalai Tesque) and 5 mM L-proline (Nacalai Tesque) at 0°C for 5 min. This procedure was repeated three times and 1 ml of ethanol : ether mixture (3:1) was added to remove TCA from the precipitates. The precipitates were redissolved in 0.1 M NaOH and neutralized with 0.1 M HCl. Radioactivity in the aliquots was measured with a scintillation counter. Aliquots were treated with 80 U/ ml type I collagenase (Sigma Chemical) for 2 h at 37°C, and the radioactivity in the collagenase-soluble fraction was measured and regarded as representative of the amount of synthesized collagen.
RESULTS
Tyrosine phosphorylation
Protein tyrosine phosphorylation was upregulated by treatment of HL, HM, and HF with PLM (Fig. 1) . In HL, PLM induced the tyrosine phosphorylation of the 116-, 98-and 56-kDa proteins at the concentration of 0.001 to 0.05 mg / ml (Fig. 1A) . In HM, protein tyrosine phosphorylation was induced by 0.01 to 0.5 mg / ml of PLM, but the phosphorylation was weak (Fig. 1B) . In HF, tyrosine phosphorylation was clearly observed in only the 116-kDa protein, and the tyrosine-phosphorylated protein was increased by treatment with 0.2 to 5 m g/ ml PLM for 15 min (Fig. 1C) .
Tyrosine phosphorylation of p56
lck and JAK3, and activation of p21 ras
Phosphorylation of p56
lck was weakly traced in nontreated HL and the phosphorylation level was increased in HL treated with PLM as well as IL-2 and TNF-a ( Fig. 2A) . When HL were cultured in the presence of 500 U/ ml IL-2, the p21 ras -binding GTP/ GDP ratio was increased in 10 min (Fig. 2B ). Similar to IL-2, PLM caused an increase of the GTP / GDP ratio in 10 min. Furthermore, the tyrosine phosphorylation of JAK3 in IL-2-treated HL was increased by the addition of PLM to the culture system (Fig. 2C) . These results were ascertained by the repeated examination. PLM activated ERK in the concentrations of 0.01 to 0.1 m g/ml in HL and HM (Fig. 3) , but PLM did not activate p38 mitogen-activated protein kinase (data not shown). Of the two bands of phosphorylated ERK, pp42 (ERK2) was more strongly upregulated.
Activation of NF-k B
The nuclear level of NF-kB differed among the cells examined (Fig. 4) . NF-kB bound to DNA was observed in untreated HM, HL and HF. Gel-shifted NF-kB was increased by treatment with PLM in all kinds of cells examined, although the increase was weak. The PLMinduced activation of NF-kB was completely suppressed by o-phenanthroline and N-acetylcysteine.
Expression of c-myc-mRNA
The expression of c-myc-mRNA, which was amplified by 30 cycles in PCR, was observed in nontreated HL, HM and HF (Fig. 5) . The expression of the proto-oncogene message was increased by PLM in HM and HF, and the increase of the message in HM was completely inhibited by N-acetylcysteine. In HM, the c-myc-mRNA expression was increased by 1-h treatment with PLM. However, 3-h treatment was needed for the increase of the mRNA expression in HF.
Cytokine generation and collagen synthesis
Cytokine generation from HL, HM and HF was enhanced by PLM; however, the optimal PLM concentration was different (Fig. 6) . In HL, generation of IL-1b , IL-6, GM-CSF and TNF-a was increased by 0.001 to 0.01 mg /ml PLM (Fig. 6A) . This cytokine generation from HM was also increased by these concentrations of PLM (Fig. 6B) . In HF, high concentrations (1 to 5 mg/ml) of PLM enhanced the generation of the cytokines (Fig. 6C) . Correspondingly, HF collagen synthesis was strongly enhanced by 1.0 mg / ml PLM (Fig. 6D) .
To analyze the linkage between the signal transducers, the cytokine generation and collagen synthesis, the influences of a tyrosine kinase inhibitor, genistein, and an ERK kinase inhibitor, PD98059, on PLM-induced cytokine generation and collagen synthesis were examined. When each kind of cells were pretreated with genistein (10 mM), the lck and activation of p21 ras and JAK3. A: HL were incubated in the presence or absence of PLM (0.01 m g/ ml), IL-2 (500 U /ml) or TNF-a (500 U /ml) for 30 min. Cell lysates were prepared and Western blotting was performed after immunoprecipitation of the lysates with anti-p56 lck mAb as described in Materials and Methods. B: HL were prelabeled with [ 32 P]orthophosphate and treated with IL-2 (500 U /ml) in the presence or absence of PLM (0.01 mg /ml). The cell lysates were immunoprecipitated with anti-p21 ras mAb and the immunoprecipitants were spotted onto a thin layer plate. After the development, autoradigraphy was performed. The GTP / GDP ratios were calculated via the use of an imaging analyzer. C: HL were pretreated with 0.01 mg /ml of PLM for 1 h and were then stimulated with 500 U /ml of IL-2 for 30 min. The cell lysates were prepared and Western blotting was performed after immunoprecipitation of lysates with anti-JAK3 mAb. Fig. 3 . Influence of PLM on ERK1 and ERK2 activation in HL and HM. HL and HM were incubated in the presence or absence of the indicated doses of PLM for 15 min. After each treatment, proteins were eluted and subjected to Western blotting analysis with anti-phosphorylated ERK1/ ERK2 mAb as described in Materials and Methods. These data are representative of three similar experiments. cytokine generation was completely suppressed, although the collagen synthesis was not completely suppressed (Fig. 7) . PD98059 also suppressed the cytokine generation and collagen synthesis, but its inhibitory activities were weaker than those of genistein (data not shown).
DISCUSSION
Multiple drugs possess pulmonary fibrosis-inducing activities, and iatrogenic pulmonary fibrosis has occasionally been observed (18, 19) . In these drugs, bleomycin and its derivative PLM are well known as the strongest inducers (1, 2) . In pulmonary fibrosis, many kinds of cells appear to be involved. As an approach to understanding the pathogenesis of drug-induced pulmonary fibrosis, the influence of drugs on the cells has to be explored.
There are multiple pathways in cell activation. Together with phosphorylation of PI, protein tyrosine phosphorylation is the first step in signal transduction, and the phosphorylation of tyrosine and serine / threonine residues is essential for signaling to the nucleus (20 -23) . In lymphocytes, p21
ras -dependent and -independent (JAK) pathways are the main routes of signal transduction of IL-2 and interferon-g (IFN-g) (16, 24) . Our present results indicate that PLM is an enhancer of signal transduction through these pathways.
Signaling via PIs and their down-stream second messengers is important for activation of cells, especially in phagocytes (25) . We had already ascertained that the levels of inositol triphosphate and intracellular Ca 2+ ([Ca
2+
]i) and protein kinase C (PKC) activity in the membrane fraction were increased with the short-term treatment of polymorphonuclear leukocytes with PLM, although the diacyl glycerol level was not significantly increased (9) . PKC activation and increase of [Ca 2+ ]i and calcineurin are required for the activation of a variety of transcription factors (26 -28) , although the activation of NF-kB is mediated by the interaction of inhibitor kB (IkB) kinase beta (IKKb) with PKCq but not PKCa, PKCz or PKCe (29, 30) . Therefore, the activation of intranuclear transcription factors was expected in PLM-treated cells in which PKC activity and [Ca
]i were increased. Gel shift assays demonstrated the activation of NF-k B.
NF-kB is an inducible transcription factor that is involved in many cellular genes for various cytokines (14, 31 -33) , acute phase proteins (34) and cell surface receptors (35, 36) . NF-kB is present in the cytoplasm in an inactive form, complexed with Ik B (14) . It has been demonstrated that various stimuli, such as viruses, lipopolysaccharides, ROI and cytokines (14, 37) activate NF-k B through dissociation of the IkB from the p65 and p50 heterodimer. In the present study, the nuclear translocation of NF-kB was increased by PLM in all kinds of cells examined. The activation of NF-k B was suppressed by the anti-oxidants o-phenanthroline and N-acetylcysteine. The suppression suggests that ROI was involved in the signaling to the NFkB activation. In fact, both antioxidants suppressed the activation of p56 lck by PLM (data not shown). We and others have already reported that PLM induces ROI generation from macrophages and neutrophils (5, 10) . Taken together with the report, the PLM-induced signal appears to be somewhere mediated by ROI.
C-myc is a proto-oncogene that is associated with cell proliferation, protein synthesis, and apoptosis (38 -41) . C-myc expression increases in the S-phase of the cell cycle and upregulates cell growth (42) . The results of PCR for c-myc expression therefore appears to be compatible with the enhanced synthesis of the cytokines and collagen.
The cytokine genes of IL-6, IL-2, TNF-a, IL-8, G-CSF, IFN-g and IFN-b are known as targets of NF-k B (14, 43) . Being coordinated with the activation of c-myc and NF-kB, the cytokine generation was evoked by PLM. The examined cytokines, IL-1b, IL-6, GM-CSF and TNF-a play a critical role in inflammation, and these cytokines with fibroblast growth factor stimulate fibroblast proliferation and collagen synthesis (44 -46) . PLM stimulated the cytokine generation by HL and HM in the low concentrations. However, the high concentrations of PLM were required to stimulate HF. The necessity of high concentrations probably depends on the sensitivity (reactivity) of HF to PLM. The low sensitivity of HF to PLM appears to be recognized by the fact that both HL and HM died within a few hours when they were cultured in the presence of 10 mg / ml, while HF survived. In the cytokine generation by HL and HM, autocrinal cytokines possibly play a critical role.
There is a report that the serum level of PLM was higher than 1.0 m g/ ml at 15 min after intravenous drip injection of 10 mg / body (47) . Taken together, this report and our experimental results, upregulated cytokine generation by HF is likely to occur in PLM-injected patients. From these findings, we concluded that PLM upregulates signal transduction in many types of cells that appear to be involved in PLM-induced pulmonary fibrosis. However, the details in the upregulated signal transduction and the role of cytokines and ROI remain to be explored.
